13.31
Rapt Therapeutics Inc Borsa (RAPT) Ultime notizie
Is RAPT Therapeutics Inc. stock overvalued or undervaluedBuild a diversified portfolio for risk mitigation - jammulinksnews.com
Should I hold or sell RAPT Therapeutics Inc. stock in 2025Superior profit margins - jammulinksnews.com
Why RAPT Therapeutics Inc. stock attracts strong analyst attentionHigh Reward Risk Balanced Trading - Newser
Lifesci Capital Weighs in on RAPT Q2 Earnings - Defense World
Rapt Therapeutics (NASDAQ:RAPT) Upgraded at Lifesci Capital - Defense World
Is RAPT Therapeutics Inc. stock overhyped or has real potentialHigh-margin investment plays - jammulinksnews.com
Is RAPT Therapeutics Inc. a good long term investmentMassive profits - Autocar Professional
What analysts say about RAPT Therapeutics Inc. stockRapid wealth accumulation - PrintWeekIndia
RAPT Therapeutics Inc. Stock Analysis and ForecastConsistent high-performance stocks - PrintWeekIndia
Can RAPT Therapeutics Inc. stock recover from recent declineExceptional earning trajectories - jammulinksnews.com
What drives RAPT Therapeutics Inc. stock priceFree Technical Analysis Support - PrintWeekIndia
Rapt Therapeutics (NASDAQ:RAPT) Receives Consensus Rating of “Hold” from Analysts - Defense World
RAPT Therapeutics: LifeSci Capital initiates Outperform with $31 PT. - AInvest
What makes RAPT Therapeutics Inc. stock price move sharplyFree Access to Investment Community - Newser
How RAPT Therapeutics Inc. stock performs during market volatilityTop Performer Shortlist - Newser
Rapt Therapeutics (RAPT) Upgraded to Strong Buy: Here's Why - Yahoo Finance
RAPT Therapeutics Explodes 20%—What's Fueling the Surge? - AInvest
RAPT Therapeutics Soars 24%—What’s Fueling the Breakout? - AInvest
Best Momentum Stocks to Buy for July 15th - TradingView
Does Rapt Therapeutics (RAPT) Have the Potential to Rally 183.83% as Wall Street Analysts Expect? - Yahoo Finance
HC Wainwright Analysts Decrease Earnings Estimates for RAPT - Defense World
HC Wainwright Forecasts Strong Price Appreciation for Rapt Therapeutics (NASDAQ:RAPT) Stock - Defense World
Rapt Therapeutics (NASDAQ:RAPT) Price Target Raised to $27.00 - Defense World
H.C. Wainwright Maintains RAPT Therapeutics(RAPT.US) With Buy Rating, Cuts Target Price to $27 - 富途牛牛
RAPT Therapeutics Unveils Plans for RPT904 Development - TipRanks
Rapt Therapeutics (NASDAQ:RAPT) Given Average Rating of “Hold” by Analysts - Defense World
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):